About Us
SyriMed is a speciality pharmaceutical company that formulates niche medicines to improve and
advance patient welfare
Who We Are
Syri Limited trading as SyriMed (formerly Thame Laboratories), is a UK based Research and Development company dedicated to revolutionising healthcare through the development of innovative and Value Added Medicines. We specialise in improving generic molecules by formulating advanced proprietary formulations adapted to the clinical needs of patients to improve their care and ease of administration.
At SyriMed, our focus is on improving patient care in critical conditions such as epilepsy, where exact dosing and dose tapering are crucial. Our liquid medicines offer precise dosing and are particularly beneficial for patients who are unable to swallow tablets, including paediatric patients and those with dysphagia. Additionally, we have developed tablets in new strengths which provide accurate dosing and easier administration for patients
Our Mission
At SyriMed, our mission is to provide exceptional care and personalised attention to our patients through our innovative medications. We are dedicated to improving the health and quality of life of patients worldwide, through the development, licensing, manufacturing, and marketing of high quality medications.
Our goal is to transcend conventional healthcare standards, making treatments more effective, accessible, and convenient for patients. We understand that each patient is unique, and we strive to understand and cater to their individual needs.
We firmly believe that patient well-being is the measure of our success. Thus, our mission goes beyond merely providing medications. It's about establishing trust, providing support, and making a positive and lasting difference in patients' lives.
At SyriMed, we are committed to bringing a brighter future for healthcare, one patient at a time.
What We Do
SyriMed maintains a close collaboration with key opinion leaders and patients to ensure that our products meet clinical and non clinical aspects such as taste, smell and administration method. This patient-centred approach has led to remarkable success stories.
Our commitment to excellence extends beyond product development. We have made significant investments in our people and state-of-the-art manufacturing and development facilities in the UK. Quality and safety are at the very centre of our organisation, our highly experienced quality and regulatory team ensure compliance with the highest industry standards.
Our products are developed in-house and are fully licensed by Regulatory Authorities globally. Our e-CTD dossiers are UK MHRA and EU compliant, ensuring the utmost quality and regulatory adherence.
Who We Are
Syri Limited trading as SyriMed (formerly Thame Laboratories), is a UK based Research and Development company dedicated to revolutionising healthcare through the development of innovative and Value Added Medicines. We specialise in improving generic molecules by formulating advanced proprietary formulations adapted to the clinical needs of patients to improve their care and ease of administration.
At SyriMed, our focus is on improving patient care in critical conditions such as epilepsy, where exact dosing and dose tapering are crucial. Our liquid medicines offer precise dosing and are particularly beneficial for patients who are unable to swallow tablets, including paediatric patients and those with dysphagia. Additionally, we have developed tablets in new strengths which provide accurate dosing and easier administration for patients
Our Mission
At SyriMed, our mission is to provide exceptional care and personalised attention to our patients through our innovative medications. We are dedicated to improving the health and quality of life of patients worldwide, through the development, licensing, manufacturing, and marketing of high quality medications.
Our goal is to transcend conventional healthcare standards, making treatments more effective, accessible, and convenient for patients. We understand that each patient is unique, and we strive to understand and cater to their individual needs.
We firmly believe that patient well-being is the measure of our success. Thus, our mission goes beyond merely providing medications. It's about establishing trust, providing support, and making a positive and lasting difference in patients' lives.
At SyriMed, we are committed to bringing a brighter future for healthcare, one patient at a time.
What We Do
SyriMed maintains a close collaboration with key opinion leaders and patients to ensure that our products meet clinical and non clinical aspects such as taste, smell and administration method. This patient-centred approach has led to remarkable success stories.
Our commitment to excellence extends beyond product development. We have made significant investments in our people and state-of-the-art manufacturing and development facilities in the UK. Quality and safety are at the very centre of our organisation, our highly experienced quality and regulatory team ensure compliance with the highest industry standards.
Our products are developed in-house and are fully licensed by Regulatory Authorities globally. Our e-CTD dossiers are UK MHRA and EU GMP compliant, guaranteeing the utmost quality and regulatory adherence.
Item code 2023/030 | Date of preparation Dec 2023
SyriMed ® is a registered trademark of Syri Limited UK